de Bono JS, Fleming MT, Wang JS, Cathomas R, et al. Phase I Study of MEDI3726: A Prostate-Specific Membrane Antigen-Targeted Antibody-Drug Conjugate, in Patients with mCRPC after Failure of Abiraterone or Enzalutamide. Clin Cancer Res 2021;27:3602-3609.
PMID: 33795255